- Hyaluronidase
drugbox
IUPAC_name = Sheep hyaluronidase
CAS_number = 488712-31-8
ATC_prefix = B06
ATC_suffix = AA03
ATC_supplemental =
PubChem =
DrugBank = BTD00022
C=2455 | H=3775 | N=617 | O=704 | S=21
molecular_weight = 53870.9 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
pregnancy_category = C
legal_status =
routes_of_administration =subcutaneous The hyaluronidases (EC number|3.2.1.35) are a family ofenzyme s that degradehyaluronic acid .By catalyzing the
hydrolysis ofhyaluronic acid , a major constituent of theinterstitial barrier, hyaluronidase lowers theviscosity of hyaluronic acid, thereby increasing tissue permeability. It is, therefore, used in medicine in conjunction with other drugs in order to speed their dispersion and delivery. The most common application is inophthalmic surgery , in which it is used in combination withlocal anesthetic s. It also increases the absorption rate ofparenteral fluids given by , and is an adjunct insubcutaneous urography for improving resorption ofradiopaque agents. Hyalurodinase is also used for extravasation of hyperosmolar solutions. usually a 0.2 ml of the drug is injected around the area of extravasation, Total of 1 ml is used.Some bacteria, such as "
Staphylococcus aureus ", "Streptococcus pyogenes ", and "Clostridium perfringens ", produce hyaluronidase as a means for greater mobility through the body's tissues and as anantigen ic disguise that prevents their being recognized byphagocytes of theimmune system .In most mammalian
fertilization , hyaluronidase is released by theacrosome of the sperm cell after it has reached theoocyte , by digesting proteins in thezona pellucida , thus enabling conception.Brand names of animal-derived hyaluronidase include HydaseTM (developed and manufactured by [http://www.primapharm.net PrimaPharm Inc.] , distributed by [http://www.akorn.com Akorn Inc.] ) which has been FDA approved as a "
Thimerosal free" animal-derived hyaluronidase, Vitrase (ISTA Pharmaceuticals), Amphadase (Amphastar Pharmaceuticals) and Wydase. Wydase, however, is no longer manufactured. OnDecember 2 ,2005 , the FDA approved a synthetic (recombinant or rDNA) "human" hyaluronidase, Hylenex (Halozyme Therapeutics ).External links
*
Wikimedia Foundation. 2010.